Curis, Inc. (CRIS)
NASDAQ·Healthcare·Biotechnology
$4.97
+2.90%
Mkt Cap $14.15M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$4.97
+2.90%
Mkt Cap $14.15M
Buy
1
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —